Halozyme Therapeutics
HALO
#2112
Rank
ยฃ5.79 B
Marketcap
ยฃ47.07
Share price
1.04%
Change (1 day)
45.56%
Change (1 year)

Halozyme Therapeutics (HALO) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : ยฃ1.33 Billion

According to Halozyme Therapeutics's latest financial reports the company's total liabilities are ยฃ1.33 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Halozyme Therapeutics - Total liabilities on balance sheet (from 2002 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31ยฃ1.29 B-6.3%
2022-12-31ยฃ1.38 B105.54%
2021-12-31ยฃ0.67 B113.67%
2020-12-31ยฃ0.31 B-12.98%
2019-12-31ยฃ0.36 B139.83%
2018-12-31ยฃ0.15 B-34.61%
2017-12-31ยฃ0.23 B-3.24%
2016-12-31ยฃ0.23 B154.41%
2015-12-31ยฃ93.65 M17%
2014-12-31ยฃ80.04 M8.42%
2013-12-31ยฃ73.82 M38.96%
2012-12-31ยฃ53.13 M50.53%
2011-12-31ยฃ35.29 M-23.25%
2010-12-31ยฃ45.98 M5.94%
2009-12-31ยฃ43.41 M3.99%
2008-12-31ยฃ41.74 M81.5%
2007-12-31ยฃ23 M95.79%
2006-12-31ยฃ11.74 M779.48%
2005-12-31ยฃ1.33 M62.36%
2004-12-31ยฃ0.82 M438.2%
2003-12-31ยฃ0.15 M-59.83%
2002-12-31ยฃ0.38 M16674.97%
2001-12-31ยฃ0 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
ยฃ0.53 B-60.34%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ50.75 B 3,691.54%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ14.75 B 1,002.22%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ99.95 B 7,367.26%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ45.02 B 3,263.76%๐Ÿ‡ซ๐Ÿ‡ท France
ยฃ85.54 B 6,290.34%๐Ÿ‡บ๐Ÿ‡ธ USA